Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Challenge Meditech is a specialized biotechnology company providing comprehensive CRO and CDMO services with a focus on peptides and oligonucleotides. Headquartered in Shanghai, the company offers a full suite of services ranging from early-stage sequence design and optimization to large-scale GMP manufacturing. Their technical expertise includes solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), and advanced modification technologies such as PEGylation and conjugation. Challenge Meditech supports global pharmaceutical and biotech partners in developing complex therapeutics for metabolic, oncological, and rare disease indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Challenge Meditech.